A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis
Xiaogang Tan(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie He(First Affiliated Hospital of Jinan University), Baozhong Li(Yanshan University), Zhaoli Chen(Tianjin haihe hospital), Keith Mitchelson(Tsinghua University), Kang Shao(Chinese Academy of Medical Sciences & Peking Union Medical College), Cuiyan Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Bin Qiu(Shandong Academy of Agricultural Sciences), Jianping Wu(Nanjing University of Chinese Medicine), Junting Wan(Chinese Academy of Medical Sciences & Peking Union Medical College), Susheng Shi(Chinese Academy of Medical Sciences & Peking Union Medical College), Shouhua Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Ning Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Xun Zhang(Zaozhuang University), Liang Zhang(Ministry of Education of the People's Republic of China), Zhen Wang(Chinese Academy of Sciences), Yong Guo(Tsinghua University), Jing Cheng(Tsinghua University), Fang Zhou(Sun Yat-sen University), Yimin Sun(Yangtze University), Xiaoli Feng(Nanjing University of Chinese Medicine), Jie Hang(Chinese Academy of Medical Sciences & Peking Union Medical College), Wenyan Qin(China Medical University), Xiaohong Zhao(Army Medical University)
Cited by 182
Related Papers
Cancer incidence and mortality in China, 2022
|Journal of the National Cancer Center|2024|2k
Cancer incidence and mortality in China, 2016
|Journal of the National Cancer Center|2022|1.6k
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application
|Drug Delivery|2021|578
Cancer registration in China and its role in cancer prevention and control
|The Lancet Oncology|2020|501